Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds

• 收藏
• 分享

专利权人:

エーザイ・アール・アンド・ディー・マネジメント株式会社

发明人:

船橋 泰博,門脇 正史,サチデーヴ パーラヴィ

申请号：

JP2015555882

公开号：

JP6411379B2

申请日:

2014.05.12

申请国别(地区):

JP

年份:

2018

代理人:

摘要：

Biomarkers are provided that predict whether a subject having endometrial cancer will or will not respond to a therapy comprising lenvatinib or a pharmaceutically acceptable salt thereof (e.g., lenvatinib mesylate). The biomarkers, compositions, and methods described herein are useful in selecting appropriate treatment modalities for and treating a subject having, suspected of having, or at risk of developing an endometrial cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/